PROCEPT BioRobotics Corporation Amortization of Intangible Assets
PROCEPT BioRobotics Corporation (PRCT) reported Amortization of Intangible Assets of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-02-26
- PROCEPT BioRobotics Corporation amortization of intangible assets for the quarter ending 2022-12-31 was $200.00K, a 100.00% increase year-over-year.
- PROCEPT BioRobotics Corporation amortization of intangible assets for the quarter ending 2022-09-30 was $100.00K, a 50.00% decline year-over-year.
- PROCEPT BioRobotics Corporation amortization of intangible assets for the quarter ending 2022-06-30 was $100.00K, a 0.00% change year-over-year.
- PROCEPT BioRobotics Corporation amortization of intangible assets for the quarter ending 2022-03-31 was $100.00K, a 0.00% change year-over-year.
- PROCEPT BioRobotics Corporation amortization of intangible assets for fiscal 2025 was $300.00K, a 0.00% change from fiscal 2024.
- PROCEPT BioRobotics Corporation amortization of intangible assets for fiscal 2024 was $300.00K, a 0.00% change from fiscal 2023.
- PROCEPT BioRobotics Corporation amortization of intangible assets for fiscal 2023 was $300.00K, a 0.00% change from fiscal 2022.
- PROCEPT BioRobotics Corporation amortization of intangible assets for fiscal 2022 was $300.00K, a 0.00% change from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $300.00K 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | $300.00K 10-K · filed 2026-02-26 | ||||
| 2023-12-31 | $300.00K 10-K · filed 2026-02-26 | ||||
| 2022-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $300.00K derived: sum of 2 quarters · filed 2025-02-27 | $400.00K derived: sum of 3 quarters · filed 2025-02-27 | $300.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | $100.00K 10-Q · filed 2022-11-04 | $200.00K derived: sum of 2 quarters · filed 2022-11-04 | $100.00K 10-Q · filed 2022-11-04 | $400.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $100.00K 10-Q · filed 2022-08-05 | $100.00K 10-Q · filed 2022-08-05 | $300.00K derived: sum of 3 quarters · filed 2024-02-28 | $500.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $100.00K 10-Q · filed 2022-05-06 | $200.00K derived: sum of 2 quarters · filed 2024-02-28 | $400.00K derived: sum of 3 quarters · filed 2024-02-28 | $500.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $300.00K derived: sum of 2 quarters · filed 2024-02-28 | $400.00K derived: sum of 3 quarters · filed 2024-02-28 | $300.00K 10-K · filed 2024-02-28 | |
| 2021-09-30 | $200.00K 10-Q · filed 2022-11-04 | $100.00K 10-Q · filed 2021-11-05 | $300.00K derived: sum of 2 quarters · filed 2022-11-04 | $200.00K 10-Q · filed 2022-11-04 | $500.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-05 | $100.00K 10-Q · filed 2022-08-05 | $300.00K derived: sum of 3 quarters · filed 2022-08-05 | $400.00K derived: sum of 4 quarters · filed 2022-08-05 | |
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-06 | $200.00K derived: sum of 2 quarters · filed 2022-05-06 | $300.00K derived: sum of 3 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $200.00K derived: sum of 2 quarters · filed 2022-03-22 | $300.00K 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $100.00K 10-Q · filed 2021-11-05 | $200.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |